These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22647362)

  • 1. MicroRNAs and prostate cancer: from preclinical research to translational oncology.
    Maugeri-Saccà M; Coppola V; Bonci D; De Maria R
    Cancer J; 2012; 18(3):253-61. PubMed ID: 22647362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs and prostate cancer.
    Coppola V; De Maria R; Bonci D
    Endocr Relat Cancer; 2010 Mar; 17(1):F1-17. PubMed ID: 19779034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
    Gordanpour A; Nam RK; Sugar L; Seth A
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of expression profiling of circulating microRNAs in men with prostate cancer.
    Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ
    BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-mediated breast cancer metastasis: from primary site to distant organs.
    Wang L; Wang J
    Oncogene; 2012 May; 31(20):2499-511. PubMed ID: 21963843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
    Abraham D; Jackson N; Gundara JS; Zhao J; Gill AJ; Delbridge L; Robinson BG; Sidhu SB
    Clin Cancer Res; 2011 Jul; 17(14):4772-81. PubMed ID: 21622722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
    Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
    Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards the definition of prostate cancer-related microRNAs: where are we now?
    Gandellini P; Folini M; Zaffaroni N
    Trends Mol Med; 2009 Sep; 15(9):381-90. PubMed ID: 19716766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional role of microRNAs in prostate cancer and therapeutic opportunities.
    Maugeri-Sacca M; Coppola V; De Maria R; Bonci D
    Crit Rev Oncog; 2013; 18(4):303-15. PubMed ID: 23614617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy.
    Cho WC
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1273-81. PubMed ID: 20026422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotype.
    Santarpia L; Nicoloso M; Calin GA
    Endocr Relat Cancer; 2010 Mar; 17(1):F51-75. PubMed ID: 19843580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
    Gandellini P; Folini M; Zaffaroni N
    Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in colorectal cancer metastasis.
    de Krijger I; Mekenkamp LJ; Punt CJ; Nagtegaal ID
    J Pathol; 2011 Aug; 224(4):438-47. PubMed ID: 21706478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers of prostate cancer outcome.
    Quinn DI; Henshall SM; Sutherland RL
    Eur J Cancer; 2005 Apr; 41(6):858-87. PubMed ID: 15808955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expressions of 6 microRNAs in prostate cancer].
    Yin Y; Li M; Li H; Jiang Y; Cao LY; Zhang HF; Xu XC
    Zhonghua Nan Ke Xue; 2010 Jul; 16(7):599-605. PubMed ID: 20873592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-mediated control of prostate cancer metastasis: implications for the identification of novel biomarkers and therapeutic targets.
    Fenderico N; Casamichele A; Profumo V; Zaffaroni N; Gandellini P
    Curr Med Chem; 2013; 20(12):1566-84. PubMed ID: 23410173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in prostate cancer: Functional role as biomarkers.
    Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
    Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New role of microRNA: carcinogenesis and clinical application in cancer.
    Zhao L; Chen X; Cao Y
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):831-9. PubMed ID: 21908856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic markers in prostate cancer.
    Ross JS; Sheehan CE; Fisher HA; Kauffman RA; Dolen EM; Kallakury BV
    Expert Rev Mol Diagn; 2002 Mar; 2(2):129-42. PubMed ID: 11962333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.
    Martens-Uzunova ES; Jalava SE; Dits NF; van Leenders GJ; Møller S; Trapman J; Bangma CH; Litman T; Visakorpi T; Jenster G
    Oncogene; 2012 Feb; 31(8):978-91. PubMed ID: 21765474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.